Pulmonary Vasculature Latest News Archive

Tricuspid Regurgitation Velocity Unreliable Indicator of Pulmonary Hypertension

Tricuspid Regurgitation Velocity Unreliable Indicator of Pulmonary Hypertension

Pulmonary hypertension was confirmed by invasive methods in 68% and 47% of patients with and without a measurable tricuspid regurgitation velocity, respectively.

Early Pulmonary Vascular Disease Onset Risk in Adults Born Preterm

Early Pulmonary Vascular Disease Onset Risk in Adults Born Preterm

Increased pulmonary pressures, right ventricular dysfunction, and a stiffer pulmonary vascular bed were typical characteristics of early pulmonary vascular disease onset in young adults who were born preterm.

PAH Mortality Rates Comparable With ERA or PDE5 Inhibitor Therapy

PAH Mortality Rates Comparable With ERA or PDE5 Inhibitor Therapy

There were no significant differences in pulmonary arterial hypertension survival based on therapy type, age was an important modifier.

Pulmonary Arterial Stiffness Related to mPAP and Heart Rate in Idiopathic PAH

Pulmonary Arterial Stiffness Related to mPAP and Heart Rate in Idiopathic PAH

Pulmonary arterial stiffness was related to mean pulmonary arterial pressure and heart rate in patients with untreated idiopathic pulmonary arterial hypertension.

Prognostic Model for Mortality in Pediatric Pulmonary Hypertension

Prognostic Model for Mortality in Pediatric Pulmonary Hypertension

The Pediatric Index Pulmonary Hypertension Intensive Care Mortality model was compared with the Pediatric Risk of Mortality 2 and 3 models to determine the best model for predicting mortality.

RV Trabecular Complexity Fractal Analysis: Measuring Remodeling in PH

RV Trabecular Complexity Fractal Analysis: Measuring Remodeling in PH

The fractal dimension of right ventricular trabecular complexity was a good reproducible marker of remodeling in pulmonary hypertension.

RV Base/Apex Ratio May Help Diagnose Pulmonary Arterial Hypertension in Children

RV Base/Apex Ratio May Help Diagnose Pulmonary Arterial Hypertension in Children

Right ventricular base/apex ratio reference values may help clinicians diagnose children with pulmonary arterial hypertension.

Improved Counseling Needed in Pregnant Patients With Pulmonary Arterial Hypertension

Improved Counseling Needed in Pregnant Patients With Pulmonary Arterial Hypertension

Many healthcare providers reported that they often do not have the time to counsel their patients with pulmonary arterial hypertension on pregnancy risks.

PAH in Congenital Heart Disease: Expert Q&A on Challenges and Advances

PAH in Congenital Heart Disease: Expert Q&A on Challenges and Advances

Management strategies were discussed for subtypes of PAH-congenital heart disease including Eisenmenger syndrome, PAH with persistent systemic to pulmonary shunts, and PAH with small or coincidental defect or PAH after defect closure.

Cyanosis From PH or Congenital Heart Disease Responds Well to IV Ferrous Carboxymaltose

Cyanosis From PH or Congenital Heart Disease Responds Well to IV Ferrous Carboxymaltose

After iron supplementation, patients with cyanosis experienced significant improvements in hemoglobin concentration, hematocrit, mean corpuscular volume, ferritin, and transferrin saturation

Sildenafil, Bosentan Combination vs Sildenafil Monotherapy in SSc-Associated PAH

Sildenafil, Bosentan Combination vs Sildenafil Monotherapy in SSc-Associated PAH

There was no significant difference in efficacy between sildenafil and bosentan initial combination therapy and sildenafil monotherapy in patients with systemic sclerosis-related pulmonary arterial hypertension.

CTEPH Increases Risk for Sleep Disordered Breathing

CTEPH Increases Risk for Sleep Disordered Breathing

Precapillary pulmonary hypertension and obstructive sleep apnea may be causative factors for central sleep apnea and pulmonary hypertension, respectively.

Arrhythmia Associated With Higher Mortality in Congenital Heart Disease-Related PAH

Arrhythmia Associated With Higher Mortality in Congenital Heart Disease-Related PAH

Arrhythmia was a significant predictor of mortality in adult patients with congenital heart disease and pulmonary arterial hypertension.

Composite Echo Score Predicts PH in Interstitial Lung Disease

Composite Echo Score Predicts PH in Interstitial Lung Disease

The variables for the stepwise echocardiographic score included right ventricular systolic pressure, early pulmonary regurgitation gradient, right atrial area size, tricuspid regurgitation velocity, left ventricle eccentricity index, and right ventricle fractional area change.

Brain Natriuretic Peptide Shows Promise as Biomarker in Group 1 PAH

Brain Natriuretic Peptide Shows Promise as Biomarker in Group 1 PAH

There was a significant relationship between brain natriuretic peptide levels and mortality in patients with group 1 pulmonary arterial hypertension.

Pulmonary Hypertension Has Adverse Effect on Post-Lung Transplant Survival

Pulmonary Hypertension Has Adverse Effect on Post-Lung Transplant Survival

The 1-year survival rate after lung transplantation in patients with a mean pulmonary arterial pressure ≥25 mm Hg was lower than the survival rate of those with a mean pulmonary arterial pressure <25 mm Hg.

Single-Beat Approach Estimates Preload Recruitable Stroke Work Relationship in PAH

Single-Beat Approach Estimates Preload Recruitable Stroke Work Relationship in PAH

A single-beat estimation of preload recruitable stroke work and its coupling with pulmonary arterial load in pulmonary arterial hypertension provided high accuracy for evaluating right ventricular contractility.

PAH Risk, Mortality Increased by Disturbances in Male Sex Hormones

PAH Risk, Mortality Increased by Disturbances in Male Sex Hormones

Men with higher estradiol and estradiol/testosterone levels had an increased risk for pulmonary arterial hypertension.

Serum Chloride Linked With Survival in Pulmonary Arterial Hypertension

Serum Chloride Linked With Survival in Pulmonary Arterial Hypertension

Serum chloride was a strong and independent predictor of mortality at 6 months after a pulmonary arterial hypertension diagnosis.

Egg-and-Banana Sign Has High Specificity for Pulmonary Hypertension Diagnosis

Egg-and-Banana Sign Has High Specificity for Pulmonary Hypertension Diagnosis

The "egg-and-banana" sign is a valid computed tomography marker of pulmonary hypertension.

Oral Anticoagulant Effective in Recurrent VTE Prevention in Cancer Patients

Oral Anticoagulant Effective in Recurrent VTE Prevention in Cancer Patients

At the end of 6 months, the rate of VTE recurrence was 4% among rivaroxaban patients vs 11% in the dalteparin arm (hazard ratio [HR] 0.43, 95% CI: 0.19 to 0.99).

Veno-Arterial Extracorporeal Membrane Oxygenation Improves Survival in Pulmonary Embolism

Veno-Arterial Extracorporeal Membrane Oxygenation Improves Survival in Pulmonary Embolism

A protocolized study including initiation of VA-ECMO may reduce mortality in patients with massive PE.

Predictive Value of Idiopathic PAH Risk Assessment Using Comorbidities, Age

Predictive Value of Idiopathic PAH Risk Assessment Using Comorbidities, Age

Ischemic heart disease and kidney dysfunction were identified as 2 comorbidities that may affect outcomes in idiopathic pulmonary arterial hypertension.

Stem Cell Therapy for RV Failure in PAH: Overview and Clinician Interview

Stem Cell Therapy for RV Failure in PAH: Overview and Clinician Interview

Stem cell therapy targeting right ventricular failure may help improve pulmonary circulation in pulmonary arterial hypertension.

Opsumit sNDA Submitted for Chronic Thromboembolic Pulmonary Hypertension

Opsumit sNDA Submitted for Chronic Thromboembolic Pulmonary Hypertension

The sNDA is accompanied by results from the MERIT-1 trial, a Phase 2 randomized, placebo-controlled, double-blind study which assessed the efficacy, safety and tolerability of macitentan 10mg in 80 patients with inoperable CTEPH.

Pulmonary Arterial Hypertension Prognosis Linked to Walking Distance

Pulmonary Arterial Hypertension Prognosis Linked to Walking Distance

Walking a distance of >400 meters in the 6-minute walk test was associated with a reduced risk for pulmonary arterial hypertension-related death or hospitalization.

Benefits of Targeted Pharmacologic Therapy in PAH and Distal CTEPH

Benefits of Targeted Pharmacologic Therapy in PAH and Distal CTEPH

In patients with pulmonary arterial hypertension or distal chronic thromboembolic pulmonary hypertension, targeted pharmacologic treatment was associated with an increase in achieved therapeutic goals.

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Increased right atrial and pulmonary wedge pressures and increased thyroid disease prevalence were associated with atrial arrhythmia development in idiopathic or systemic sclerosis-related pulmonary arterial hypertension.

Oral Treprostinil Dosing Characteristics in Pulmonary Arterial Hypertension

Oral Treprostinil Dosing Characteristics in Pulmonary Arterial Hypertension

Prescribers tend to favor a frequency of 3 times per day for oral treprostinil dosing in patients with pulmonary arterial hypertension.

Pulmonary Hypertension Outcomes Predicted by NT-pro BNP

Pulmonary Hypertension Outcomes Predicted by NT-pro BNP

N-terminal-pro brain natriuretic peptide may be a useful biomarker for both mortality and respiratory exacerbations in pediatric patients with pulmonary hypertension.

Pulmonary Hypertension Mortality Following Cardiac Catheterization

Pulmonary Hypertension Mortality Following Cardiac Catheterization

Patients with pulmonary hypertension have a high risk for adverse events during and following cardiac catheterization, but high case volume may help ameliorate this risk.

PDE-5 Inhibitor Prescribing Trends Do Not Meet Pulmonary Hypertension Guidelines

PDE-5 Inhibitor Prescribing Trends Do Not Meet Pulmonary Hypertension Guidelines

Nearly two-thirds of phosphodiesterase-5 inhibitor prescriptions are inconsistent with pulmonary hypertension guidelines.

Pulmonary Arterial Hypertension Identified Via Claims-Based Algorithm

Pulmonary Arterial Hypertension Identified Via Claims-Based Algorithm

Patients with pulmonary arterial hypertension may be better identified with the use of a claims-based algorithm that includes ICD-9-CM codes, electronic medical records, and more.

Right Atrium Enlargement Predicts Supraventricular Arrhythmia Risk in PAH

Right Atrium Enlargement Predicts Supraventricular Arrhythmia Risk in PAH

Right atrium enlargement may predict the risk for supraventricular arrhythmias in patients with pulmonary arterial hypertension.

Long-Term Prognosis in Women vs Men With Pulmonary Arterial Hypertension

Long-Term Prognosis in Women vs Men With Pulmonary Arterial Hypertension

Women with pulmonary arterial hypertension may have better long-term prognoses compared with men, potentially because of improvements in right ventricular function.

Pulmonary Embolism Rule-Out Criteria Can Identify Thromboembolic Events

Pulmonary Embolism Rule-Out Criteria Can Identify Thromboembolic Events

A 3-month risk for a thromboembolic event was assessed using a pulmonary embolism rule-out criteria strategy and compared with a conventional strategy in patients with a low clinical probability of pulmonary embolism.

Pulmonary Embolism With Low Mortality Risk Treated in Outpatient Setting

Pulmonary Embolism With Low Mortality Risk Treated in Outpatient Setting

Acute pulmonary embolism may be managed in an outpatient setting when the patient has a low risk for mortality.

Idiopathic PAH-Associated Hypoxemia Linked to Poor Survival, Increased Comorbidities

Idiopathic PAH-Associated Hypoxemia Linked to Poor Survival, Increased Comorbidities

Hypoxemia is associated with reduced survival in patients with idiopathic or heritable pulmonary arterial hypertension.

Peak Circulatory Power Is a Potent Predictive Tool in Idiopathic PAH

Peak Circulatory Power Is a Potent Predictive Tool in Idiopathic PAH

Peak circulatory may provide reliable prognostic information in patients with idiopathic pulmonary arterial hypertension.

6MWT Clinically Relevant and Appropriate Prognostic Tool for PAH

6MWT Clinically Relevant and Appropriate Prognostic Tool for PAH

The 6MWT is a clinically relevant and appropriate target for patients with pulmonary arterial hypertension.

Pulmonary Embolism Risk Prediction in Postpartum Women

Pulmonary Embolism Risk Prediction in Postpartum Women

Certain risk scores may not be reliable for predicting the presence of a pulmonary embolism in pregnant or postpartum women.

Pulmonary Hypertension Treatments Targeting NO Pathway Compared for Safety

Pulmonary Hypertension Treatments Targeting NO Pathway Compared for Safety

Several drugs may demonstrate different safety profiles and side effects that warrant a change in treatment for individuals with pulmonary hypertension.

Two 6-Minute Walk Tests Recommended for Suspected Pulmonary Hypertension

Two 6-Minute Walk Tests Recommended for Suspected Pulmonary Hypertension

To minimize the "learning effect" and improve accuracy, patients with suspected pulmonary hypertension should undergo two 6-minute walk tests.

Pulmonary Arterial Hypertension: Biomarker May Predict 5-Year Survival

Pulmonary Arterial Hypertension: Biomarker May Predict 5-Year Survival

Monitoring the plasma BNP level in individuals with pulmonary arterial hypertension may aid clinicians in therapeutic decision-making and overall prediction of 5-year survival rate.

Global Pulmonary Vascular Remodeling and Pulmonary Hypertension in Heart Failure

Global Pulmonary Vascular Remodeling and Pulmonary Hypertension in Heart Failure

Researchers discovered an association between global pulmonary vascular remodeling and pulmonary hypertension in patients with heart failure.

Assessment of Ambrisentan in Pulmonary Arterial Hypertension

Assessment of Ambrisentan in Pulmonary Arterial Hypertension

In a postmarketing surveillance study, ambrisentan demonstrated tolerability and potential effectiveness for pulmonary arterial hypertension treatment.

Intermediate-Risk Pulmonary Embolism Treatment With Dabigatran

Intermediate-Risk Pulmonary Embolism Treatment With Dabigatran

Patients diagnosed with an intermediate-risk pulmonary embolism may be able to start oral anticoagulation therapy after completing 72 hours of heparin therapy during hospitalization.

Pilot Study to Assess Effectiveness of Milrinone in Congenital Diaphragmatic Hernia

Pilot Study to Assess Effectiveness of Milrinone in Congenital Diaphragmatic Hernia

A pilot study will assess the effectiveness of milrinone in a small group of infants born with congenital diaphragmatic hernia.

Pulmonary Hypertension vs Age for Predicting Outcomes in Heart Transplant

Pulmonary Hypertension vs Age for Predicting Outcomes in Heart Transplant

Compared with age, pulmonary hypertension, right ventricular failure, and cardiopulmonary bypass time may better predict outcomes in heart transplantation.

Implantable Treprostinil Delivery System Shows Promise for Managing PAH

Implantable Treprostinil Delivery System Shows Promise for Managing PAH

Treprostinil, a prostacyclin derivative, used in an implantable delivery system may be an effective treatment alternative for pulmonary arterial hypertension.

PAH Long-Term Survival Predicted by Reliable Risk Calculator

PAH Long-Term Survival Predicted by Reliable Risk Calculator

Researchers examined the effect of riociguat compared with placebo on the REVEAL risk score and long-term outcomes for pulmonary arterial hypertension.

Smoke-Free Ordinances Lower Lung Cancer Risk

Smoke-Free Ordinances Lower Lung Cancer Risk

Smoke-free ordinances may reduce the number of lung cancer cases.

PAH: eGFR Changes May Predict Survival, Hospitalizations

PAH: eGFR Changes May Predict Survival, Hospitalizations

A decrease in baseline estimated glomerular filtration rate in PAH may be a predictor of hospitalization and mortality.

Intermediate-Risk Pulmonary Emboli: Catheter-Directed vs Systemic Thrombolysis

Intermediate-Risk Pulmonary Emboli: Catheter-Directed vs Systemic Thrombolysis

Catheter-directed thrombolysis vs systemic thrombolysis strategies show different risk outcomes for patients with intermediate-risk pulmonary embolism.

Pediatric Pulmonary Embolism: 9 Predictors Identified

Pediatric Pulmonary Embolism: 9 Predictors Identified

Several clinical predictors of pediatric pulmonary embolism have been identified.

Oral Riociguat May Have Clinical Utility in Severe Pediatric Pulmonary Arterial Hypertension

Oral Riociguat May Have Clinical Utility in Severe Pediatric Pulmonary Arterial Hypertension

Use of riociguat may be considered for severe pulmonary arterial hypertension in pediatric patients.

Balloon Pulmonary Angioplasty Improves Hemodynamics in CTEPH

Balloon Pulmonary Angioplasty Improves Hemodynamics in CTEPH

Balloon pulmonary angioplasty may improve hemodynamics in patients with CTEPH.

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

Patients with pulmonary arterial hypertension may have an impaired cerebral pressure-flow relationship.

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

Switching from a phosphodiesterase type 5 inhibitor to riociguat significantly improves pulmonary arterial compliance in patients with PAH.

Predicting Mortality in PAH With Congenital Heart Disease

Predicting Mortality in PAH With Congenital Heart Disease

Pulmonary artery compliance may be an independent predictor of survival and prognosis in patients with pulmonary artery hypertension associated with congenital heart disease.

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

Nebulized glycopyrrolate improves lung function and patient-reported outcomes in patients with moderate to very severe COPD.

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

Pulmonary arterial hypertension associated with the use of methamphetamine is a severe, progressive form of the disease.

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

Patients with hereditary hemorrhagic telangiectasia may develop pulmonary hypertension.

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

Patients with chronic thromboembolic pulmonary hypertension may have higher rates of depression compared to patients with PAH.

Prognostic Value of CT Signs of Pulmonary Veno-occlusive Disease

Prognostic Value of CT Signs of Pulmonary Veno-occlusive Disease

Having at least 2 features of pulmonary veno-occlusive disease is linked to reduced survival rate in patients with SSc and PAH.

Right Ventricular Morphology Predicts Type of Pulmonary Hypertension

Right Ventricular Morphology Predicts Type of Pulmonary Hypertension

Right ventricular base/apex ratio during systole can discriminate between types of pulmonary hypertension.

Anxiety and Depression Affect Quality of Life in Idiopathic Pulmonary Fibrosis

Anxiety and Depression Affect Quality of Life in Idiopathic Pulmonary Fibrosis

Quality of life in patients with idiopathic pulmonary fibrosis can be significantly affected by depression and anxiety.

No Difference in Short-Term Outcomes in Saddle vs Nonsaddle Pulmonary Embolism

No Difference in Short-Term Outcomes in Saddle vs Nonsaddle Pulmonary Embolism

Patients with saddle and nonsaddle pulmonary embolism have similar short-term outcomes, despite more serious symptoms being present in saddle pulmonary embolism.

ESC: New Guidelines Recommend Multidisciplinary Approach for Peripheral Arterial Disease

ESC: New Guidelines Recommend Multidisciplinary Approach for Peripheral Arterial Disease

The European Society of Cardiology and the European Society for Vascular Surgery have developed new guidelines on the diagnosis and treatment of peripheral arterial disease.

High- vs Low-Risk Obstructive Sleep Apnea Leads to Longer Hospitalizations

High- vs Low-Risk Obstructive Sleep Apnea Leads to Longer Hospitalizations

Patients with high-risk obstructive sleep apnea are almost 4 times more likely to have postoperative complications vs patients with low-risk obstructive sleep apnea.

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

Pulmonary endarterectomy is an effective treatment for patients with chronic thromboembolic pulmonary hypertension.

Hypercoagulability in Sleep Apnea Can Increase Risk for CV Complications

Hypercoagulability in Sleep Apnea Can Increase Risk for CV Complications

People with obstructive sleep apnea could have a higher risk for hypercoagulability.

FDA Approves Bosentan for Pediatric Pulmonary Arterial Hypertension

FDA Approves Bosentan for Pediatric Pulmonary Arterial Hypertension

Bosentan has been approved for use in pediatric pulmonary arterial hypertension in children aged 3 years or older.

Selexipag Associated With Reduced Morbidity, Mortality Risk in Connective Tissue Disease-Associated PAH

Selexipag Associated With Reduced Morbidity, Mortality Risk in Connective Tissue Disease-Associated PAH

In patients with connective tissue disease-associated pulmonary arterial hypertension, selexipag may reduce risk for morbidity and mortality.

Survival in SLE-Related Pulmonary Arterial Hypertension Linked to Autoimmune Antibodies

Survival in SLE-Related Pulmonary Arterial Hypertension Linked to Autoimmune Antibodies

Anti-U1 ribonucleoprotein antibodies may increase chances of survival in patients with pulmonary arterial hypertension as a complication of systemic lupus erythematosus.

Coronary Artery Disease-Related Death Increased With Opioid Use in COPD

Coronary Artery Disease-Related Death Increased With Opioid Use in COPD

Opioid use increases cardiac event risk in older adults with chronic obstructive pulmonary disease.

Pulmonary Artery-to-Aorta Ratio May Predict Survival in Idiopathic Pulmonary Fibrosis

Pulmonary Artery-to-Aorta Ratio May Predict Survival in Idiopathic Pulmonary Fibrosis

Pulmonary artery to aorta ratio measurement can effectively predict survival in patients with idiopathic pulmonary fibrosis.

Sarcoidosis-Associated Pulmonary Hypertension: Predicting Factors for Reduced 6MWD

Sarcoidosis-Associated Pulmonary Hypertension: Predicting Factors for Reduced 6MWD

Multiple factors have influenced a 6-minute reduction in sarcoidosis-associated pulmonary hypertension.

Peripheral Artery Disease-Related Leg Ischemia and Antihypertensive Use

Peripheral Artery Disease-Related Leg Ischemia and Antihypertensive Use

Mean arterial pressure in patients with peripheral artery disease decreased as a result of antihypertensive medication.

Biomarkers Linking SLE-Associated Pulmonary Arterial Hypertension

Biomarkers Linking SLE-Associated Pulmonary Arterial Hypertension

Mortality rates in SLE-associated pulmonary arterial hypertension are higher compared to the general SLE population even-though diagnostic and treatment strategy have improved in the last 50 years.

Arterial Stiffness May Be Predicted by Restrictive Spirometry Pattern

Arterial Stiffness May Be Predicted by Restrictive Spirometry Pattern

Restrictive spirometry pattern and reduced forced vital capacity (FVC) are associated with a higher risk for arterial stiffness regardless of sex.

Reducing Amputation Risk in Diabetes With Peripheral Artery Disease

Reducing Amputation Risk in Diabetes With Peripheral Artery Disease

Researchers examined statin therapy as a method of risk reduction in lower extremity amputation.

Right Upper Extremity Deep Vein Thrombosis: A Case Study

Right Upper Extremity Deep Vein Thrombosis: A Case Study

A case study of a patient presented to the emergency room for right upper extremity deep vein thrombosis after rib resection and subclavian vein stent placement 15 years ago.

Venous Thromboembolism and Sepsis Risks Increase With Short-Term Oral Corticosteriods

Venous Thromboembolism and Sepsis Risks Increase With Short-Term Oral Corticosteriods

An increased risk of sepsis, venous thromboembolism and fracture was linked to short term use of oral corticosteroids.

Cardiovascular Risks Not Increased With Long-Acting Beta2-Agonist for COPD

Cardiovascular Risks Not Increased With Long-Acting Beta2-Agonist for COPD

Combination therapy with an inhaled long-acting beta2-agonist and an inhaled corticosteroid did not affect all-cause mortality compared with inhaled placebo.

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

Results from the EINSTEIN CHOICE trial plus an interview with investigator Philip Stephen Wells, MD, FRCP(C), MSc.

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Survival rates were high for patients with both central and peripheral pulmonary emboli.

Statin Use May Reduce Mortality in COPD Patients

Statin Use May Reduce Mortality in COPD Patients

While data are conflicting, statin use in COPD may help reduce pulmonary-related and all-cause mortality.

Intracerebral Hemorrhage: Trends in Medical Complications

Intracerebral Hemorrhage: Trends in Medical Complications

After intracerebral hemorrhage, both acute renal failure and deep venous thrombosis have increased.

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

Pulmonary embolism risk after cerebral venous thromboembolism is significantly lower than after deep vein thromboembolism.

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Patients with giant cell arteritis were more likely to experience venous thromboembolism during the first 3 months following diagnosis.

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

Initial combination therapy with ambrisentan and tadalafil reduced the risk for first clinical failure event in patients with connective tissue disease-associated pulmonary arterial hypertension.

Resistant Hypertension May Increase Sleep Apnea Risk

Resistant Hypertension May Increase Sleep Apnea Risk

Patients with resistant hypertension had a modest increase in risk of developing sleep apnea compared to those with nonresistant hypertension.

New Metabolites Associated With Hemodynamic Indicators of Right Ventricular-Pulmonary Vascular Dysfunction Discovered

New Metabolites Associated With Hemodynamic Indicators of Right Ventricular-Pulmonary Vascular Dysfunction Discovered

Researchers discovered 21 new metabolites associated with 2 or more hemodynamic indicators of right ventricular-pulmonary vascular function.

Treatment and Length of Stay Changes Reduce Pulmonary Embolism Mortality

Treatment and Length of Stay Changes Reduce Pulmonary Embolism Mortality

RIETE registry reveals an association between improved hospital care and reduced pulmonary embolism mortality.

Dabigatran Approved for Prophylaxis of DVT and Pulmonary Embolism

Dabigatran Approved for Prophylaxis of DVT and Pulmonary Embolism

Dabigatran now approved for prohylaxis of deep vein thrombosis and pulmonary embolism in patients who have undergone hip replacement surgery.

Peripherally Inserted Central Catheters Increase Lower Extremity DVT, PE

Peripherally Inserted Central Catheters Increase Lower Extremity DVT, PE

Before inserting peripherally placed central catheters (PICCs), physicians should weigh potential risks for each patient with the ultimate clinical benefit.

Extensive Television Watching Increases Pulmonary Embolism Risk

Extensive Television Watching Increases Pulmonary Embolism Risk

Prolonged television watchers have an increased risk of pulmonary embolism mortality.

Exercise Improves Quality of Life in Pulmonary Hypertension

Exercise Improves Quality of Life in Pulmonary Hypertension

Researchers analyze the efficacy and safety of exercise training in pulmonary hypertension.

Sign Up for Free e-Newsletters